SYVC Stock Chart & Stats
$0.01
<$0.01(9900.00%)
At close: 4:00 PM EDT
$0.01
<$0.01(9900.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume14.93K
Average Volume (3M)0.00
Market Cap
$2.98K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-16.76
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding29,827,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SYVC FAQ
What was Synovics Pharmaceuticals Inc’s price range in the past 12 months?
Synovics Pharmaceuticals Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Synovics Pharmaceuticals Inc’s market cap?
Synovics Pharmaceuticals Inc’s market cap is $2.98K.
When is Synovics Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Synovics Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Synovics Pharmaceuticals Inc overvalued?
According to Wall Street analysts Synovics Pharmaceuticals Inc’s price is currently Overvalued.
Does Synovics Pharmaceuticals Inc pay dividends?
Synovics Pharmaceuticals Inc does not currently pay dividends.
What is Synovics Pharmaceuticals Inc’s EPS estimate?
Synovics Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Synovics Pharmaceuticals Inc have?
Synovics Pharmaceuticals Inc has 29,827,000 shares outstanding.
What happened to Synovics Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Synovics Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in SYVC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Synovics Pharmaceuticals Inc
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives. It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States. The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006. Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.